Biotechnology Stock Review ? Arena, where it's been, where it's going

14-12-2010 Beacon Equity ResearchComments (0)


Arena Pharmaceuticals Inc. (NASDAQ: ARNA) last week announced the commencement of patient dosing in a phase I clinical trial of APD811, a new oral drug ...

Read more on Beacon Equity Research

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top